Emgality™ Financial Assistance Guide

CHAMP has created the financial assistance guide below for anyone who has been prescribed EmgalityTM by their healthcare provider. Emgality™ is one of three new CGRP inhibitors that were approved for the prevention of migraine in adults. If you or someone you know requires help with paying for treatment, please review the details provided below to see if you qualify for the manufacturer’s financial assistance programs and how best to access Emgality™.

Please note: This guide has not been produced or approved by the manufacturer of Emgality™. CHAMP does not endorse the use of any CGRP inhibitor over another, nor promotes the use of this new class of preventive medications for everyone with migraine disease. Please consult your healthcare provider to determine if CGRP inhibitors are right for you.